CANCER DRIVER INTERCEPTION, Systemic Inflammation, Gut Dysbiosis, Genomic Instability, Immune System Deficiency, PRENATAL SCREENING, G-TEST, ULTRANIPT , ULTRANIPT DG, OMNIPT, Inherited Metabolic Disorder, Severe Combined Immunodeficiency, Lysosomal Storage Diseases, CANCER EARLY DETECTION, Solid Cancer, Breast and Ovary, Lung, Colon and rectum, Genome Instability, AESTHETICS STEM CELLS, Skin Rejuvenation, Face Reshaping, Breast augmentation, Buttock enhancement, Scar Reduction, Hair Loss, Female rejuvenation, Penis enlargment, HEREDITARY CANCERS DRIVERS, Endometrium, Colon, Solid Cancers, Breast and Ovary, REGENERATIVE STEM CELLS, Orthopedics, Premature Ovarian Failure, Erectile dysfunction, Anti-aging Therapy iV, Empty Nose Syndrome, Body Performance, Supportive Care, CANCER DIAGNOSIS, Colon and Rectum, Breast, Ovary and Prostate, Lung Cancer Assay, Liquid Biopsy, STEM CELL EXOSOMES, Skin Aging, Hair Loss, Orthopedics, Erectile Dysfunction, Female Rejuvenation, Body Performance, Anti-Ageing, PREVENTIVE CANCER THERAPY, Systemic Inflammation, Dysbiosis, Genomic Instability, Immune Deficiency, STEM CELL BANKING, Cord Blood Derived, Cord Tissue Derived, Adipose Tissue Derived, EXOSOME COSMETICS, X-FILL – Eye & Lip Contour, X-LIFT – Firm Facial Lifting, X-SKIN- Advanced Moisturizing, X-HAIR – Hair Loss Treatment
Skip to main content

遗传性癌症基因易感性检测

癌症遗传易感性是由基因突变引起的,这种基因突变可以从父母传给下一代,从而增加个体患癌症的风险。此项基因检测,目的是在癌症发展之前就发现它,并阻止癌症易感性,使得健康人群能通过此检测时刻监控个体癌症风险情况

MyCheck 癌症基因检测手册

MyCheck Cancer tests

使用基于下一代测序 (NGS) 的分析,我们提供多种检测选择,通过研究分析与特定癌症直接相关的基因的靶向基因数据。我们的 MyCheck 测试用于检测特定的、可遗传的、与疾病相关的基因突变,这些基因突变可能会增加某些癌症的风险,从而可以对每位患者进行深入的癌症风险评估。

男性Mycheck 癌症基因检测

有BRCA 1 和 2 基因突变的男性,患乳腺癌和前列腺癌的风险将增加。 MyCheck Cancer Male 将这些和其他基因包括在单个多基因面板测试中

Mycheck 肠癌基因检测

大约 5% 到 10% 的结肠癌是遗传性的。使用 MyCheck 肠癌基因检测,可以分析与遗传性结肠癌风险有关的基因

MyCheck 乳腺癌基因检测

当 BRCA 基因发生突变,就会增加一个人患乳腺癌的风险。 MyCheck 乳房测试旨在确定您的 DNA 是否发生了会增加患这种癌症风险的变化。

×

Information Request








    Privacy Policy (*)